Creative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs is offering the most comprehensive services for antibody development projects. With strict regulation and effective execution, we are dedicated to providing the most valuable solutions to complete your projects.
HighlightsCreative Biolabs has established a broad range of platforms for developing novel antibodies or equivalents. These cutting-edge technologies enable our scientists to meet your demands from different aspects and tailor the most appropriate solution that contributes to the success of your projects.
HighlightsWith deep understanding in antibody-related realms and extensive project experience, Creative Biolabs offers a variety of references to help you learn more about our capacities and achievements, including infographic, flyer, case study, peer-reviewed publications, and all kinds of knowledge that can assist your projects. You are also welcome to contact us directly for more specific solutions.
HighlightsGet a real taste of Creative Biolabs, one of the most professional custom service providers in the world. We are committed to providing highly customized comprehensive solutions with the best quality to advance your projects.
Highlights
Loading...All listed services and products are For Research Use Only. Do Not use in any diagnostic or therapeutic applications.
Angiotensin II receptor type 1 (AGTR1) is a class A seven-transmembrane G protein-coupled receptor encoded by the AGTR1 gene, anchored to plasma membrane bilayers across cardiovascular and renal somatic cell populations. Unlike soluble cytoplasmic enzymes without lipid-binding segments, AGTR1 contains seven continuous hydrophobic transmembrane helices and extracellular ligand-binding loops that support peptide ligand recognition at cell surface compartments. It appears to operate as a membrane signaling transducer to relay extracellular peptide hormone signals into intracellular signaling cascades under physiological conditions. Unbalanced peptide ligand signaling at cell membrane receptors tends to shift downstream messenger levels without AGTR1-mediated buffering, and AGTR1 establishes moderate signal homeostasis tuning to stabilize intracellular messenger concentrations across diverse tissue microenvironments. Distinct tissue subtypes generate unique pools of endogenous peptide ligands, requiring coordinated GPCR signaling networks to sustain balanced fluid and pressure regulation within organ compartments. Membrane-localized AGTR1 may continuously interact with circulating peptide ligands to moderate downstream messenger accumulation and preserve cardiovascular tissue equilibrium. Stable membrane residence of AGTR1 maintained by conserved palmitoylation motifs avoids irregular receptor internalization and degradation cycles, a state that might disrupt consistent signal transmission between extracellular hormonal cues and intracellular effector machinery across cardiovascular tissue subtypes.
AGTR1 may mediate intracellular signal cascades triggered by internalized peptide-hormone complexes. Sequence variants within the AGTR1 gene shift peptide ligand binding affinity and correlate with disrupted tissue signaling states. No other class A GPCR fully recapitulates AGTR1's dual capacity for peptide ligand sensing and G-protein effector coupling at plasma membranes. Fluctuations in AGTR1 expression levels likely correspond to tissue fluid and pressure regulatory status, rendering the receptor a suitable research target for GPCR structural biology and cardiovascular signal analysis. AGTR1 localizes exclusively to plasma membrane outer surfaces to transmit extracellular peptide signals without entering cytoplasmic organelle luminal compartments. Its integral membrane topology separates it from soluble cytoplasmic enzymes, with dual potential roles in sustaining tissue signaling balance and mediating intercellular hormonal communication. AGTR1-coupled G-protein signaling may adjust cytoplasmic messenger concentrations and modify cellular ion transport activity. Reduced functional AGTR1 elevates unregulated downstream messenger levels and weakens membrane ligand response capacity, making AGTR1 a research subject for basic class A GPCR functional studies.
Fig. 1 Two‑dimensional domain topology of human AGTR1. This schematic shows extracellular N‑terminal segment, seven hydrophobic transmembrane helices spanning lipid bilayer, intra‑ and extracellular loops and C‑terminal segment, as well as annotated disulfide‑bond and N‑glycosylation sites relevant for receptor folding and membrane localization.1
The biological functions of integral membrane AGTR1 GPCR are focused on sustained peptide ligand recognition and intracellular messenger cascade transduction:
Creative Biolabs offers purified AGTR1 membrane protein samples produced under unified preparation workflows, including full-length AGTR1 constructs and isolated extracellular ligand-binding domain variants. Truncated receptor fragments cannot support complete peptide ligand recognition and G-protein coupling activity, while full-length constructs fit research focused on membrane receptor-ligand interaction and GPCR conformational analysis. All batches receive uniform quality screening. Functional assessments may only be performed on full-length membrane receptor under simulated lipid bilayer microenvironment setups. Consistent extracellular ligand-binding domain structural features are preserved across batches to support comparative laboratory analysis between experimental groups. Full-length AGTR1 membrane samples retain intact extracellular ligand-binding pocket conformation after standardized purification, which supports reliable detection of weak and transient ligand-receptor binding events in comparative membrane functional analysis.
Not finding the Membrane Protein product you need? Contact us to start your one-stop custom service!
Creative Biolabs provides cell research models with adjustable AGTR1 expression levels, suitable for structural observation of integral membrane GPCRs and research into membrane peptide ligand interaction processing. Sample assessment covers sustained target membrane expression detection and preliminary ligand-receptor interaction analysis, enabling side-by-side comparison of receptor conformational behavior under varying membrane expression abundances. These cell models can be paired with diverse laboratory analysis schemes to track shifts in ligand response efficiency alongside changing target membrane protein levels.
Not finding the stable cell line product you need? Contact us to start your one-stop custom service!
Anti-AGTR1 recombinant antibodies are generated via standardized protein preparation workflows, compatible with routine laboratory detection techniques for plasma membrane localization mapping and identification of ligand-receptor complexes. The antibody series works with common laboratory detection reagents to support multi-dimensional observation of target membrane distribution within tissue samples.
Not finding the recombinant antibody product you need? Contact us to start your one-stop custom service!
Beyond catalog products, Creative Biolabs offers specialized custom services for AGTR1 research:
AGTR1 may act as an integral membrane GPCR and participate in transmembrane transmission of vasoactive peptide hormone signals.
AGTR1 expression status may alter membrane peptide ligand response capacity and intracellular messenger cascade output, serving as a key mediator of cardiovascular tissue signaling biological processes.
No, all AGTR1 related products and services are strictly for research use only, and cannot be applied in clinical workflows. All material design and functional screening are optimized exclusively for basic laboratory research, without meeting clinical application criteria.
Offerings include full-length AGTR1 membrane protein, target-specific recombinant antibodies and tunable expression cell research models, supporting research on membrane receptor-peptide ligand binding and cardiovascular signal transduction.
Laboratory analysis schemes may include peptide ligand binding assays to assess its peptide recognition capacity under simulated lipid bilayer environments.
